Summary of the bill.
The bill proposes to promote Panama’s domestic pharmaceutical industry through a revised classification of laboratories. It sets eligibility requirements for industry incentives and amends rules for public procurement of medicines and other health supplies, covering notice periods, submission of bids, contractor selection and penalties for breach of contract.